- The efficacy of donepezil for the treatment of Alzheimer’s disease
Samuel L. Warren et al, 2022, Alzheimer's Disease CrossRef - Multi‐fluorine labeled indanone derivatives as potential MRI imaging probes for β‐Amyloid plaques
Yaqian Dai et al, 2023, Chemical Biology & Drug Design CrossRef - Thymus vulgaris Essential Oil Protects Zebrafish against Cognitive Dysfunction by Regulating Cholinergic and Antioxidants Systems
Luminita Capatina et al, 2020, Antioxidants CrossRef - Quality-by-design driven analytical method (AQbD) development and validation of HPLC–UV technique to quantify rivastigmine hydrogen tartrate in lipidic nanocarriers: Forced degradation, and assessment of drug content and in vitro release studies
null Salwa et al, 2023, Microchemical Journal CrossRef - Effect of donepezil hydrochloride on the transgenic Drosophila expressing human Aβ-42
Yasir Hasan Siddique et al, 2023, International Journal of Neuroscience CrossRef - Acetylcholinesterase inhibitors (Galantamine, Rivastigmine, and Donepezil)
Gumpeny R. Sridhar, 2021, NeuroPsychopharmacotherapy CrossRef - Acetylcholinesterase inhibitors (Galantamine, Rivastigmine, and Donepezil)
Gumpeny R. Sridhar, 2022, NeuroPsychopharmacotherapy CrossRef - Uso dos antagonistas dos receptores de bradicinina na doença de Alzheimer
Divane Hannah Nóbrega de Melo et al, 2022, Revista Contemporânea CrossRef - Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling
Jieun Kim et al, 2021, International Journal of Molecular Sciences CrossRef - Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
Gemma García-Lluch et al, 2023, Pharmaceutics CrossRef - Donepezil-based combination therapy for Alzheimer’s disease and related neuropathies
Bidemi Emmanuel Ekundayo et al, 2023, Comparative Clinical Pathology CrossRef - Available Treatment Modules for Brain Disorders
Tehreem Iman et al, 2023, The Role of Natural Antioxidants in Brain Disorders CrossRef